Research  |  Core Facilities  |  Patient Studies  |  Tech Transfer  |  Seminars  |  Intranet  |  Jobs  |  Search  |  Contact Us  |  Ways To Give                             HOME  
 

 

More about
Dr. Taylor:

Dr. Taylor's profile

Dr. Taylor 101
(for non-scientists)

Dr. Taylor's CV in brief

Publications

Cardiovascular Biology Research Program

 

 

Fletcher B. Taylor, M.D.
Member, Cardiovascular Biology Research Program
Adjunct Professor, Departments of Pathology, Biochemistry & Molecular Biology
  and Physiology & Biophysics
George Lynn Cross Research Professor, University of Oklahoma Health Sciences
  Center
OMRF Distinguished Career Scientist


Recent Publications
Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT.  Extracellular histones are major mediators of death in sepsis.  Nat Med 15:1318-1321, 2009.  [Abstract]

Binette TM, Taylor FB Jr, Peer G, Bajzar L.  Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.  Blood 110:3168-3175, 2007.  [Abstract]

Samis JA, Stewart KA, Nesheim ME, Taylor FB Jr.  Factor V cleavage and inactivation are temporally associated with elevated elastase during experimental sepsis.  J Thromb Haemost 5:2559-2561, 2007.  [Abstract]

Selected Publications
Samis JA, Stewart KA, Nesheim ME, Taylor FB Jr. Time-dependent association between coagulation factor inactivation and increased elastase during experimental sepsis. J Thromb Haemost 7:1032-1034, 2009. [Abstract]

Mehta A, Brewington R, Chatterji M, Zoubine M, Kinasewitz GT, Peer GT, Chang ACK, Taylor FB and Shnyra A. Infection-induced modulation of M1 and M2 phenotypes in circulating monocytes: Role in immune monitoring and early prognosis of sepsis. Shock 22:423-430, 2004. [Abstract]

Taylor FB and Kinasewitz G. Activated protein C in sepsis. J Thromb Haemost 2:708-717, 2004. [Abstract]

Siegler RL, Obrig TG, Pysher TJ, Tesh VL, Denkers ND and Taylor FB. Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr Nephrol 18:92-96, 2003. [Abstract]

Taylor F, Jr. comment of "Drotrecogin Alfa (activated) (recombinant human protein C, rhAPC) reduces host coagulopathy response in patients with severe sepsis." Thromb Haemost 90:560-561, 2003. [Abstract]

Pysher TJ, Siegler RL, Tech VL, Taylor FB Jr. von Willebrand factor expression in a Shiga toxin-mediated primate model of hemolytic uremic syndrome. Pediatr Dev Pathol 5:472-479, 2002. [Abstract]

 

Email This PageEmail this page